Technologies
PDF


WARF: P100069US01

Microfluidic Device for Capturing and Analyzing Rare Cells, Including Circulating Tumor Cells


INVENTORS -

David Beebe, Jay Warrick, Erwin Berthier

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a microfluidic device that enables cells to be collected from a relatively dilute suspension and then stained and imaged in the collection area.
OVERVIEWCirculating tumor cells (CTC) are an important area of cancer research.  They could provide clinically relevant information about a patient’s prognosis.  However, these cells are extremely rare (roughly one to 100 cells per mL of whole blood), and their concentration is only about 500 cells per 100 uL after purification and subsequent concentration via centrifugiation.  This makes it difficult to culture and analyze these cells.

Methods for concentrating and counting CTC have been developed, but these methods can be harsh or prone to cell loss, or are feasible only on the macro-scale.  Additionally, they are not suitable for detailed analysis of CTC or amenable to cell culture. 
THE INVENTIONUW-Madison researchers have developed a microfluidic device for concentrating rare cells.  The velocity of flow through the device is manipulated such that particles in suspension, such as cells, are carried to and deposited in a particular location within the device.  The flow in the region where the cells are deposited is slow, so the cells remain in the collection area without any modifications to the surfaces of the device or cells while the fluid that carried them is routed out of the device.  Because particles in suspension enter the collection region but do not leave, many particles may be captured from a relatively dilute suspension.  The cells then can be cultured, stained and imaged for analysis without being removed from the collection area, creating a gentle and efficient way to implement extensive washing and treatment protocols.
APPLICATIONS
  • Concentrating rare cells
  • Counting, treating and identifying cells
  • Culturing rare or delicate cell types
  • Analyzing non-adherent or lightly adhering cells
KEY BENEFITS
  • Allows many particles or cells to be collected from a relatively dilute suspension without requiring device or cell surface modifications
  • Increases cell concentration by at least an order of magnitude
  • Enables initial treatment, culture and subsequent staining and imaging to occur in the same device
  • Device components can be added easily to most existing microfluidic designs.
STAGE OF DEVELOPMENTA device has been built and currently is being used in collaboration with a clinical trial of a prostate cancer treatment.
ADDITIONAL INFORMATION
For More Information About the Inventors
Contact Information
For current licensing status, please contact Jeanine Burmania at jeanine@warf.org or 608-960-9846.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.